Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
Hao, J., Chen, H., Madigan, Michele, Cozzi, Paul, Beretov, Julia, Xiao, W., Delprado, Warick, Russell, Pamela, & Li, Yong (2010) Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. British Journal of Cancer, 103(7), pp. 1008-1018.
Impact and interest:
Citation countsare sourced monthly fromand citation databases.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||prostate cancer, CD147, CD44v3-10, monocarboxylate transporters, multidrug resistance, metastasis|
|Subjects:||Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200)|
|Divisions:||Current > QUT Faculties and Divisions > Faculty of Health|
Current > Institutes > Institute of Health and Biomedical Innovation
|Deposited On:||13 Jul 2011 23:08|
|Last Modified:||03 Dec 2012 12:07|
Repository Staff Only: item control page